Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jed E Rose

Showing results (31-40 of 113) with videos related to

Pageof 12
Sort By:
Psychopharmacology|December 25, 2008
24-h smoking abstinence potentiates fMRI-BOLD activation to smoking cues in cerebral cortex and dorsal striatumF Joseph McClernon, Rachel V Kozink, Avery M Lutz, et al.
Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco|July 2, 2009
Precessation treatment with nicotine patch significantly increases abstinence rates relative to conventional treatmentJed E Rose, Joseph E Herskovic, Frederique M Behm, et al.
Iscience|December 2, 2024
Personalized and adaptive interventions for smoking cessation: Emerging trends and determinants of efficacyGal Cohen, Carlo Maria Bellanca, Renato Bernardini, et al.
Pharmacology, Biochemistry, and Behavior|November 1, 2003
Mecamylamine acutely increases human intravenous nicotine self-administrationJed E Rose, Frederique M Behm, Eric C Westman, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|May 28, 2005
Abstinence-induced changes in self-report craving correlate with event-related FMRI responses to smoking cuesF Joseph McClernon, F Berry Hiott, Scott A Huettel, et al.
Molecular Medicine (Cambridge, Mass.)|April 10, 2010
Personalized smoking cessation: interactions between nicotine dose, dependence and quit-success genotype scoreJed E Rose, Frédérique M Behm, Tomas Drgon, et al.
Pharmacology, Biochemistry, and Behavior|January 24, 2015
Bupropion-varenicline interactions and nicotine self-administration behavior in ratsBrandon J Hall, Susan Slade, Corinne Wells, et al.
Experimental and Clinical Psychopharmacology|October 14, 2010
Pulmonary delivery of nicotine pyruvate: sensory and pharmacokinetic characteristicsJed E Rose, James E Turner, Thangaraju Murugesan, et al.
Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco|November 6, 2016
Lorcaserin for Smoking Cessation and Associated Weight Gain: A Randomized 12-Week Clinical TrialWilliam R Shanahan, Jed E Rose, Alan Glicklich, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|April 22, 2015
Increased Functional Connectivity in an Insula-Based Network is Associated with Improved Smoking Cessation OutcomesMerideth A Addicott, Maggie M Sweitzer, Brett Froeliger, et al.
Pageof 12

Showing results (31-40 of 113) with videos related to

Sort By:
Pageof 12
Psychopharmacology|December 25, 2008
24-h smoking abstinence potentiates fMRI-BOLD activation to smoking cues in cerebral cortex and dorsal striatumF Joseph McClernon, Rachel V Kozink, Avery M Lutz, et al.
Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco|July 2, 2009
Precessation treatment with nicotine patch significantly increases abstinence rates relative to conventional treatmentJed E Rose, Joseph E Herskovic, Frederique M Behm, et al.
Iscience|December 2, 2024
Personalized and adaptive interventions for smoking cessation: Emerging trends and determinants of efficacyGal Cohen, Carlo Maria Bellanca, Renato Bernardini, et al.
Pharmacology, Biochemistry, and Behavior|November 1, 2003
Mecamylamine acutely increases human intravenous nicotine self-administrationJed E Rose, Frederique M Behm, Eric C Westman, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|May 28, 2005
Abstinence-induced changes in self-report craving correlate with event-related FMRI responses to smoking cuesF Joseph McClernon, F Berry Hiott, Scott A Huettel, et al.
Molecular Medicine (Cambridge, Mass.)|April 10, 2010
Personalized smoking cessation: interactions between nicotine dose, dependence and quit-success genotype scoreJed E Rose, Frédérique M Behm, Tomas Drgon, et al.
Pharmacology, Biochemistry, and Behavior|January 24, 2015
Bupropion-varenicline interactions and nicotine self-administration behavior in ratsBrandon J Hall, Susan Slade, Corinne Wells, et al.
Experimental and Clinical Psychopharmacology|October 14, 2010
Pulmonary delivery of nicotine pyruvate: sensory and pharmacokinetic characteristicsJed E Rose, James E Turner, Thangaraju Murugesan, et al.
Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco|November 6, 2016
Lorcaserin for Smoking Cessation and Associated Weight Gain: A Randomized 12-Week Clinical TrialWilliam R Shanahan, Jed E Rose, Alan Glicklich, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|April 22, 2015
Increased Functional Connectivity in an Insula-Based Network is Associated with Improved Smoking Cessation OutcomesMerideth A Addicott, Maggie M Sweitzer, Brett Froeliger, et al.
Pageof 12